Equities

Linike Medical Group Ltd

LNMG:PKC

Linike Medical Group Ltd

Actions
  • Price (USD)0.315
  • Today's Change-0.118 / -27.25%
  • Shares traded153.66k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 20:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Linike Medical Group Ltd (LNMG:PKC) closed at 0.315, 50.00% above the 52 week low of 0.21 set on Sep 09, 2024.
52-week range
Today
0.21Sep 09 20241.50Aug 12 2024
Open0.4125
High0.4125
Low0.2921
Bid--
Offer--
Previous close0.433
Average volume50.65k
Shares outstanding668.95m
Free float632.56m
P/E (TTM)--
Market cap210.72m USD
EPS (TTM)-0.1102
USD
Data delayed at least 15 minutes, as of Nov 21 2024 20:20 GMT.
More ▼

Events & Activity

  • LNMG:PKC trading volume exceeds daily average by +196.09%
  • LNMG:PKC price moved over -14.11% to 0.3951
  • LNMG:PKC price falls below 15-day moving average to 0.43 at 12:14 GMT
  • LNMG:PKC price falls below 15-day moving average to 0.3951 at 12:37 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.